129 related articles for article (PubMed ID: 2691456)
1. Immunoscintigraphy of melanoma using radiolabelled antibodies: pilot, prospective studies and Italian multicenter clinical trials.
Buraggi GL; Gasparini M
Int J Rad Appl Instrum B; 1989; 16(6):629-32. PubMed ID: 2691456
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunodetection of malignant melanoma with the 225.28S monoclonal antibody to HMW-MAA.
Buraggi GL
Nuklearmedizin; 1986 Dec; 25(6):220-4. PubMed ID: 3808962
[TBL] [Abstract][Full Text] [Related]
3. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.
Siccardi AG; Buraggi GL; Callegaro L; Mariani G; Natali PG; Abbati A; Bestagno M; Caputo V; Mansi L; Masi R
Cancer Res; 1986 Sep; 46(9):4817-22. PubMed ID: 3731128
[TBL] [Abstract][Full Text] [Related]
4. Immunoscintigraphy of melanoma and of CEA-secreting carcinomas. Multicenter studies of the Italian National Research Council.
Siccardi AG
Int J Rad Appl Instrum B; 1989; 16(6):637-9. PubMed ID: 2691457
[No Abstract] [Full Text] [Related]
5. Tumor immunoscintigraphy by means of radiolabeled monoclonal antibodies: multicenter studies of the Italian National Research Council--Special Project "Biomedical Engineering".
Siccardi AG
Cancer Res; 1990 Feb; 50(3 Suppl):899s-903s. PubMed ID: 2404584
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunodetection of melanoma: preliminary results of a prospective study.
Buraggi G; Turrin A; Cascinelli N; Attili A; Gasparini M; Callegaro L; Ferrone S; Seregni E; Bombardieri E; Belli F
Int J Biol Markers; 1986; 1(1):47-54. PubMed ID: 2826619
[TBL] [Abstract][Full Text] [Related]
7. [Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma].
Rentsch M; Cerny T; Richner J; Brunner KW; Rösler H; Nachbur B
Helv Chir Acta; 1989 Jun; 56(1-2):11-3. PubMed ID: 2777587
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy with 123I, 99mTc and 111In-labelled F(ab')2 fragments of monoclonal antibodies to a human high molecular weight-melanoma associated antigen.
Buraggi GL; Callegaro L; Turrin A; Cascinelli N; Attili A; Emanuelli H; Gasparini M; Deleide G; Plassio G; Dovis M
J Nucl Med Allied Sci; 1984; 28(4):283-95. PubMed ID: 6535835
[No Abstract] [Full Text] [Related]
9. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
[TBL] [Abstract][Full Text] [Related]
10. [Immunoscintigraphy of malignant melanoma].
Nicol L; Sandron A; Herry JY; Chevrant-Breton J
Pathol Biol (Paris); 1990 Oct; 38(8):866-9. PubMed ID: 2274393
[TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results.
Modorati G; Brancato R; Paganelli G; Magnani P; Pavoni R; Fazio F
Br J Ophthalmol; 1994 Jan; 78(1):19-23. PubMed ID: 8110692
[TBL] [Abstract][Full Text] [Related]
12. Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma.
Cerny T; Owens SE; Mackenzie SA; Nuttall PM; Gosh AK; Smith DB; Thatcher N
Eur J Nucl Med; 1987; 13(3):130-3. PubMed ID: 3622556
[TBL] [Abstract][Full Text] [Related]
13. [Anti-melanoma immunoscintigraphy].
Santos AI; Godinho F
Acta Med Port; 1995 Jan; 8(1):49-55. PubMed ID: 7747612
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
15. [Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma].
Dudczak R; Kletter K; Bailer H; Kokoschka E; Pohl-Markl H
Wien Klin Wochenschr; 1987 Apr; 99(7):232-9. PubMed ID: 3590802
[TBL] [Abstract][Full Text] [Related]
16. The clinical status of immunoscintigraphy with monoclonal antibodies in ocular melanoma.
Schaling DF; Jager MJ; van Kroonenburg MJ; Oosterhuis JA; Pauwels EK
Int J Biol Markers; 1991; 6(1):25-30. PubMed ID: 1856514
[TBL] [Abstract][Full Text] [Related]
17. Immunoscintigraphy for ocular melanoma: a reliable diagnostic technique?
Loeffler KU; Bräutigam P; Simon JC; Althauser SR; Wuttig C; Witschel H
Graefes Arch Clin Exp Ophthalmol; 1996 Feb; 234(2):100-4. PubMed ID: 8720679
[TBL] [Abstract][Full Text] [Related]
18. Immunoscintigraphy in intraocular malignant melanoma.
Scheidhauer K; Markl A; Leinsinger G; Moser E; Scheiffarth OF; Riedel KG; Schaal TS; Stefani FH; Schumacher U
Nucl Med Commun; 1988 Sep; 9(9):669-78. PubMed ID: 3263596
[TBL] [Abstract][Full Text] [Related]
19. Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma.
Böni R; Huch Böni RA; Steinert H; Dummer R; Burg G; von Schulthess GK
Dermatology; 1995; 191(2):119-23. PubMed ID: 8520057
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of ocular melanoma with cutaneous melanoma antibodies.
Bomanji J; Garner A; Prasad J; Albert DM; Hungerford JL; Granowska M; Britton KE
Br J Ophthalmol; 1987 Sep; 71(9):647-50. PubMed ID: 3311140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
